Abstract

of Plans This section received an evaluation of Excellent to Very Good in 2000, primarily because sufficient evidence of a strategic planning process was lacking. Program planning and evaluation have been dramatically improved with a formal process in place since 2001. We believe that a strategic plan begins with a vision for the Center, followed by specific goals and pathways towards those goals. Essential components of the planning process are tools to measure progress and evaluate the performance of the Center. These premises formed the basis of a strategic planning process that was activated in August 2001, entitled """"""""Charting the Future Course of the Moores Cancer Center."""""""" The Plan was enthusiastically endorsed by the External Advisory Board in June 2002, and was revised in November 2003 following appointment of Dennis Carson as Center Director. Use of Past CCSG Funds The current CCSG budget for Planning and Evaluation is $58,500. Funds were spent as budgeted over the past project period. Annual Center-wide retreats were held in Borrego Springs during 2002-2005. EAB meetings were held in June 2002, May 2005 and March 2006. Travel funds were used by the leadership to attend Cancer Center-related meetings, including: NCI Directors;AACI;CCAF;and Cancer Prevention and Control Leaders. CCSG was also used to help defray costs of divisional retreats and seminars and symposia.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA023100-27S9
Application #
8653399
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2011-05-01
Budget End
2013-04-30
Support Year
27
Fiscal Year
2013
Total Cost
$52,477
Indirect Cost
$18,116

  Institution

Name
University of California San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093

  Publications

Liu, Liang; Yang, Lin; Yan, Wei et al. (2018) Chemotherapy Induces Breast Cancer Stemness in Association with Dysregulated Monocytosis. Clin Cancer Res 24:2370-2382
Lwin, Thinzar M; Murakami, Takashi; Miyake, Kentaro et al. (2018) Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore. Ann Surg Oncol 25:1079-1085
Singh, Siddharth; Loomba, Rohit (2018) Role of two-dimensional shear wave elastography in the assessment of chronic liver diseases. Hepatology 67:13-15
Hartman, Sheri J; Nelson, Sandahl H; Myers, Emily et al. (2018) Randomized controlled trial of increasing physical activity on objectively measured and self-reported cognitive functioning among breast cancer survivors: The memory & motion study. Cancer 124:192-202
Hoffmann, Hanne M; Gong, Ping; Tamrazian, Anika et al. (2018) Transcriptional interaction between cFOS and the homeodomain-binding transcription factor VAX1 on the GnRH promoter controls Gnrh1 expression levels in a GnRH neuron maturation specific manner. Mol Cell Endocrinol 461:143-154
Liu, Xuxiang; Cao, Minghui; Palomares, Melanie et al. (2018) Metastatic breast cancer cells overexpress and secrete miR-218 to regulate type I collagen deposition by osteoblasts. Breast Cancer Res 20:127
Huang, Justin K; Carlin, Daniel E; Yu, Michael Ku et al. (2018) Systematic Evaluation of Molecular Networks for Discovery of Disease Genes. Cell Syst 6:484-495.e5
Kalyanaraman, Hema; Schwaerzer, Gerburg; Ramdani, Ghania et al. (2018) Protein Kinase G Activation Reverses Oxidative Stress and Restores Osteoblast Function and Bone Formation in Male Mice With Type 1 Diabetes. Diabetes 67:607-623
Hartman, Sheri J; Marinac, Catherine R; Cadmus-Bertram, Lisa et al. (2018) Sedentary Behaviors and Biomarkers Among Breast Cancer Survivors. J Phys Act Health 15:1-6
Wu, Yan; Tamayo, Pablo; Zhang, Kun (2018) Visualizing and Interpreting Single-Cell Gene Expression Datasets with Similarity Weighted Nonnegative Embedding. Cell Syst 7:656-666.e4

Showing the most recent 10 out of 862 publications